Searchable abstracts of presentations at key conferences on calcified tissues

ba0005p418 | Osteoporosis: treatment | ECTS2016

Globular adiponectin reverses trabecular osteopenia in ovariectomized rats

Pal China Shyamsundar , Porwal Konica , Kushwaha Sapana , Gurjar Anagha , Singh Abhishek , Sanyal Sabyasachi , Chattopadhyay Naibedya

Adiponectin has recently been shown to influence skeletal metabolism. Over-expression of adiponectin gene suppresses bone resorption and increases trabecular bone mass. Bone marrow stromal cells from adiponectin-null mice had reduced mineralized nodule formation ability compared with wild type mice. Adiponectin, signalling via the adiponectin receptor 1 (AdipoR1) stimulates osteoblast differentiation and inhibits osteoclastogenesis. We have shown that the globular for...

ba0002lb2 | (1) | ICCBH2013

WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta identify a key WNT ligand regulating bone mass

Laine Christine , Joeng Kyu Sang , Campeau Philippe , Kiviranta Riku , Tarkkonen Kati , Grover Monica , Lu James , Pekkinen Minna , Wessman Maija , Heino Terhi , Nieminen-Pihala Vappu , Laine Tero , Kroger Heikki , Cole William , Lehesjoki Anna-Elina , Krakow Deborah , Curry Cynthia , Cohn Daniel , Gibbs Richard , Lee Brendan , Makitie Outi

The role of the WNT pathway in skeletal maintenance has been extensively studied since the identification of mutations in key signaling WNT mediators (LRP5 and sclerostin) in high and low bone mass phenotypes. However, the identity of the key WNT ligand that signals via LRP5/6 has remained unknown. We aimed to identify genes with a major effect on the skeleton by studying individuals and families with early-onset osteoporosis or osteogenesis imperfecta (OI).<p class="abste...

ba0001pp84 | Bone development/growth and fracture repair | ECTS2013

Variations in osteotoxic effects of cadmium on femoral bone structure after different routes of exposure

Martiniakova Monika , Chovancova Hana , Omelka Radoslav , Bobonova Ivana , Toman Robert

Cadmium (Cd) is regarded as a risk factor for various bone diseases in humans and experimental animals. To compare effects of different routes of Cd administration on femoral bone structure, ten 4-month-old male Wistar rats (group A) were injected intraperitoneally with a single dose of 2 mg CdCl2/kg body weight and killed 36 h after Cd had been injected. Ten 1-month-old male rats (group B) were dosed with a daily Cd intake of 30 mg CdCl2/l in drinking wa...

ba0001pp260 | Chondrocytes and cartilage | ECTS2013

Dietary 2-oxoglutarate protects femoral cartilage of 9 months male pigs prenatally treated with dexamethasone

Tomaszewska Ewa , Dobrowolski Piotr , Hulas-Stasiak Monika , Kurlak Paulina

Our earlier results indicate that prenatal exposure to dexamethasone, synthetic glucocorticoid, may disturb metabolic processes in skeletal system with long-term consequences. Functional foods show a beneficial action that improve the state of health and reduce the risk of disease. The study was performed to determine whether 2-oxoglutaric acid (2-Ox) can abolish the growth inhibiting effect of prenatally administered dexamethasone (DEX) manifested in the growth plate and arti...

ba0003pp196 | Genetics | ECTS2014

Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) with clinical indicators of osteoporosis in postmenopausal Slovak women

Krajcovicova Vladimira , Durisova Jana , Galbavy Drahomir , Martiniakova Monika , Omelka Radoslav

Objective: The enzyme methylenetetrahydrofolate reductase (MTHFR) is known to play an important role in the removal of circulating homocysteine via the methionine cycle. C677T polymorphism is associated with higher plasma homocysteine levels, which could affect collagen maturation. The aim of the present study was to examine possible associations of C677T polymorphism in the MTHFR gene with a variability of femoral (F-BMD), spinal BMD (S-BMD) together with circulating...

ba0005p170 | Cell biology: osteoblasts and bone formation | ECTS2016

Matrix vesicle-mediated mineralization depends on the balance between annexins and fetuin-A which may be modulated by TNAP and calcium channel inhibitors

Strzelecka-Kiliszek Agnieszka , Bozycki Lukasz , Roszkowska Monika , Pikula Slawomir

Bone mineralization is initiated by matrix vesicles (MVs), cell-derived structures released into the extracellular matrix which are nucleation sites for hydroxyapatite (HA) formation. It is suggested that annexins are mineralization-stimulating membrane proteins that exhibit ion channel activity and facilitate the influx of Ca2+ into MVs. The process is also regulated via enzymatic degradation of inhibitory pyrophosphate by tissue-nonspecific alkaline phosphatase (T...

ba0006p023 | (1) | ICCBH2017

Tracking differences in morphology and regulation between the spine and long bones in a pig model

Raimann Adalbert , Javanmardi Alireza , Egerbacher Monika , Haeusler Gabriele

Objectives: The skeleton is not a single functional unit but consists of different, well-organized and mineralized compartments with specific functions, developmental aspects and regulations. Differences in the regulation of spinal and long bone elongation are mirrored clinically by the age course in body proportions. Whereas growth plates (GPs) in long bones can easily be discriminated, vertebral GPs are part of the cartilaginous endplate, which typically shows important spec...

ba0001pp131 | Calciotropic and phosphotropic hormones and mineral metabolism | ECTS2013

Effects of zoledronic acid on hormone levels in premenopausal women with breast cancer receiving neoadjuvant or adjuvant chemotherapy and endocrine therapy: Probone II Study

Hadji Peyman , Kauka Anette , Bauer Thomas , Ziller May , Birkholz Katrin , Baier Monika , Muth Mathias , Kann Peter

Introduction: Loss in bone mineral density may occur soon after initiation of adjuvant therapy for hormone-receptor-positive (HR+), breast cancer (BC) and correlates with changes in hormone levels. Adding zoledronic acid (ZOL) to adjuvant treatment for BC can preserve/improve bone mineral density and delay disease recurrence; however, effects of ZOL on endocrine hormone levels are currently unclear.Methods: Probone II assessed the course of endocrine hor...

ba0001pp161 | Cancer and bone: basic, translational and clinical | ECTS2013

Effect of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for breast cancer: the ProBONE II Study

Hadji Peyman , Kauka Anette , Bauer Thomas , Birkholz Katrin , Baier Monika , Muth Mathias Muth , Ziller May

Introduction: Bone mineral density (BMD) evaluations have shown that adjuvant chemotherapy or endocrine therapy (ET) for early breast cancer (BC) is associated with accelerated BMD loss and increased fracture risk. In recent studies, zoledronic acid (ZOL) increased BMD in premenopausal and postmenopausal women with BC, and improved disease-free survival in some patient subsets compared with no ZOL. The purpose of the current study was to investigate the effect of adjuvant trea...

ba0001pp261 | Chondrocytes and cartilage | ECTS2013

Prenatally administered acrylamide programs a gut-bone axis of guinea pig newborns

Tomaszewska Ewa , Dobrowolski Piotr , Kurlak Paulina , Badzian Barbara , Hulas-Stasiak Monika , Puzio Iwona , Kostro Krzysztof

Acrylamide is a byproduct that forms when certain carbohydrate and aminoacid rich foods are fried, baked, or roasted at high temperatures (>120°C). Our earlier study showed that acrylamide altered the morphology and histology of the small intestinal wall damaging the intestinal barrier and reducing absorption surface. The study was performed to determine whether acrylamide influences gut-bone axis in foetus when administered to guinea pig during the last 35 days of pr...